Last update 27 Jan 2026

Padoprazan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
DW-4421, ID-120040002, ID120040002
Target
H+/K+ ATPase
Action-
Mechanism
P-CAB(Potassium-competitive acid blockers)
Therapeutic Areas
Digestive System DisordersMouth and Tooth DiseasesOtorhinolaryngologic Diseases
Active Indication
Gastroesophageal Reflux
Inactive Indication-
Originator Organization
Ildong Pharmaceutical Co., Ltd.Ildong Pharmaceutical Co., Ltd.
Active Organization
Ildong Pharmaceutical Co., Ltd.Ildong Pharmaceutical Co., Ltd.Daewon Pharmaceutical Co., Ltd.Daewon Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization
YUNOVIA CO.,LTD.Daewon Pharmaceutical Co., Ltd.Daewon Pharmaceutical Co., Ltd.
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC19H20FN3O4S
InChIKeyUDMABANYJMEZDH-UHFFFAOYSA-N
CAS Registry2756367-23-2

Related

5
Clinical Trials associated with Padoprazan
NCT07364851
/ Not yet recruitingPhase 1
A Randomized, Open-label, Single-dose, 2-sequence, Two-period, Crossover Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics After Administration of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers
NCT07364877
/ Enrolling by invitationPhase 1
A Randomized, Open-label, Single-dose, 2-sequence, Two-period, Crossover Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics After Administration of DW4421 and DW4421S in Healthy Adult Volunteers
NCT07343245
/ RecruitingPhase 1
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics Drug-Drug Interaction of DW4421 and 3 NSAIDs in Healthy Adult Volunteers
100 Clinical Results associated with Padoprazan
Login to view more data
100 Translational Medicine associated with Padoprazan
Login to view more data
100 Patents (Medical) associated with Padoprazan
Login to view more data
100 Deals associated with Padoprazan
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Gastroesophageal RefluxPhase 2
South Korea
Ildong Pharmaceutical Co., Ltd.Ildong Pharmaceutical Co., Ltd.
01 Nov 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free